JP Morgan Chase’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

JP Morgan Chase’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-185	Closed	-$816	–	8075
2023 Q4	$816	Buy	185 +184	+18,400%	+$645	﹤0.01%	6863
2023 Q3	$6	Buy	+1	New	+$10	﹤0.01%	7352
2022 Q2	–	Sell	-113	Closed	-$5K	–	7025
2022 Q1	$5K	Buy	113 +23	+26%	+$1.38K	﹤0.01%	6333
2021 Q4	$6K	Hold	90	–	–	﹤0.01%	6404
2021 Q3	$13K	Hold	90	–	–	﹤0.01%	6126
2021 Q2	$55K	Buy	+90	New	+$58.7K	﹤0.01%	5711

JP Morgan Chase's MDVL Position: Q1 2024 in Review

JP Morgan Chase sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 185 shares — an estimated $816 sold.

JP Morgan Chase first reported a position in MDVL in Q2 2021 and held it in 6 quarters. The position peaked at $55K in Q2 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

JP Morgan Chase reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
JP Morgan Chase sold 185 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $816.
JP Morgan Chase first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
JP Morgan Chase's MedAvail Holdings, Inc. Common Stock position peaked at $55K in Q2 2021.
1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.